Valuation: Amgen Inc.

Market Cap 199B 174B 160B 148B 281B 18,957B 286B 1,919B 752B 9,309B 746B 729B 32,246B P/E 2026 *
24.1x
P/E 2027 * 22.1x
Enterprise Value 241B 211B 194B 180B 341B 22,973B 347B 2,325B 911B 11,281B 904B 884B 39,077B EV / Sales 2026 *
6.37x
EV / Sales 2027 * 6.08x
Free-Float
99.78%
Yield 2026 *
2.74%
Yield 2027 * 2.9%
1 day-1.21%
1 week-3.10%
Current month+0.12%
1 month+5.22%
3 months+1.96%
6 months+11.18%
Current year+10.77%
1 week 359.47
Extreme 359.4695
375.25
1 month 334.05
Extreme 334.0501
375.25
Current year 318.21
Extreme 318.21
391.29
1 year 269.77
Extreme 269.77
391.29
3 years 218.61
Extreme 218.61
391.29
5 years 198.64
Extreme 198.64
391.29
10 years 133.64
Extreme 133.64
391.29
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 62 2010-05-12
Director of Finance/CFO 67 2019-12-31
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap.
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.24%-3.10%+22.27%+61.33% 199B
-0.04%+0.06%+54.35%+168.03% 1,084B
-1.33%-1.26%+66.20%+62.83% 634B
-1.17%-4.53%+30.75%+85.33% 447B
+0.18%-1.76%+29.04%+26.48% 330B
-6.22%-8.14%+28.87%+31.18% 295B
-1.27%-2.91%+27.42%+44.91% 285B
-0.93%-3.57%-27.74%-39.70% 218B
-1.32%+1.84%+18.06%+76.63% 169B
+0.85%-0.37%-5.20%-32.09% 137B
Average -1.26%+2.34%+24.40%+48.49% 379.69B
Weighted average by Cap. -1.09%+2.42%+37.20%+79.77%

Financials

2026 *2027 *
Net sales 37.77B 33.04B 30.47B 28.19B 53.52B 3,606B 54.41B 365B 143B 1,771B 142B 139B 6,133B 38.7B 33.86B 31.22B 28.89B 54.83B 3,694B 55.75B 374B 147B 1,814B 145B 142B 6,284B
Net income 8.23B 7.2B 6.64B 6.14B 11.66B 786B 11.86B 79.52B 31.17B 386B 30.9B 30.23B 1,336B 8.86B 7.75B 7.15B 6.62B 12.56B 846B 12.77B 85.64B 33.57B 416B 33.28B 32.56B 1,439B
Net Debt 42.07B 36.8B 33.94B 31.4B 59.6B 4,016B 60.6B 406B 159B 1,972B 158B 155B 6,830B 36.52B 31.94B 29.46B 27.26B 51.73B 3,485B 52.6B 353B 138B 1,712B 137B 134B 5,929B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-07-09 $362.45 -1.51% 682,006
26-07-08 $367.99 -0.03% 1,758,925
26-07-07 $368.10 +0.45% 1,983,666
26-07-06 $366.44 -2.06% 2,838,007
26-07-02 $374.15 +3.55% 2,487,837
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
367.99USD
Average target price
354.97USD
Spread / Average Target
-3.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock